Particular interaction between efavirenz and the HIV-1 reverse transcriptase binding site as explained by the ONIOM2 method

被引：23
|
作者：
Nunrium, P
Kuno, M
Saen-Oon, S
Hannongbua, S
机构：
[1] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok 10900, Thailand
[2] Srinakharinwirot Univ, Dept Chem, Bangkok 10330, Thailand
[3] Chulalongkorn Univ, Dept Chem, Computat Chem Unit Cell, Bangkok 10330, Thailand
来源：
CHEMICAL PHYSICS LETTERS | 2005年 / 405卷 / 1-3期
关键词：
D O I：
10.1016/j.cplett.2005.02.023
中图分类号：
O64 [物理化学（理论化学）、化学物理学];
学科分类号：
070304 ; 081704 ;
摘要：
Particular interaction between efavirenz and the HIV-1 reverse transcriptase binding site was investigated, based on the B3LYP/ 6-31G(d,p) and ONIOM2 methods. The interaction between efavirenz and Lys101 was found to be the strongest interaction, typically, -11.29 kcal/mol. The stability of this complex system leads to the foundation of the estimated binding energy of approximately -22.66 kcal/mol. Moreover, two hydrogen bonds between benzoxazin-2-one, and the backbone carbonyl oxygen and the backbone amino hydrogen of Lys101 were observed. These hydrogen bond interactions play an important role in the bound efavirenz/HIV-1 RT complex. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码：198 / 202
页数：5
相关论文
共 50 条
  • [21] Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding
    Sluis-Cremer, N
    Temiz, NA
    Bahar, I
    CURRENT HIV RESEARCH, 2004, 2 (04) : 323 - 332
  • [22] New Efavirenz Derivatives and 1,2,3-Triazolyl-phosphonates as Inhibitors of Reverse Transcriptase of HIV-1
    Costa, Carolina C. P.
    Boechat, Nubia
    Bastos, Monica M.
    da Silva, Fernando de C.
    Marttorelli, Andressa
    Souza, Thiago M. L.
    Baptista, Mayara S.
    Hoelz, Lucas V. B.
    Cafffarena, Ernesto R.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (17) : 1494 - 1505
  • [23] Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase
    Boyer, PL
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3056 - 3061
  • [24] Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase
    Gupta, Pawan
    Kumar, Rajender
    Garg, Prabha
    Singh, Inder Pal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4427 - 4431
  • [25] Practical asymmetric synthesis of efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor
    Pierce, ME
    Parsons, RL
    Radesca, LA
    Lo, YS
    Silverman, S
    Moore, JR
    Islam, Q
    Choudhury, A
    Fortunak, JMD
    Nguyen, D
    Luo, C
    Morgan, SJ
    Davis, WP
    Confalone, PN
    Chen, CY
    Tillyer, RD
    Frey, L
    Tan, LS
    Xu, F
    Zhao, DL
    Thompson, AS
    Corley, EG
    Grabowski, EJJ
    Reamer, R
    Reider, PJ
    JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (23): : 8536 - 8543
  • [26] Effect of the Allosteric Inhibitor Efavirenz on HIV-1 Reverse Transcriptase by Molecular Dynamics Simulation
    Meng Xian-Mei
    Zhang Shao-Long
    Zhang Qing-Gang
    ACTA PHYSICO-CHIMICA SINICA, 2016, 32 (02) : 436 - 444
  • [27] NEVIRAPINE BINDING DOMAIN FROM HIV-1 REVERSE-TRANSCRIPTASE CONFERS SENSITIVITY TO HIV-2 REVERSE-TRANSCRIPTASE
    BACOLLA, A
    HANSEN, GL
    ROSE, JM
    SHIH, CK
    GRIFFIN, JA
    FASEB JOURNAL, 1992, 6 (01): : A60 - A60
  • [28] Revealing Interaction Mode Between HIV-1 Reverse Transcriptase and Diaryltriazine Analog Inhibitor
    Li, Zeng
    Han, Jin
    Chen, Hai-Feng
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (05) : 350 - 359
  • [29] Inhibition of HIV-1 reverse transcriptase and its binding to HIV-1 integrase by modified oligonucleotides
    Korolev, S.
    Kondrashina, O.
    Lysenko, E.
    Gottikh, M.
    FEBS JOURNAL, 2013, 280 : 84 - 85
  • [30] ACTIVE-SITE LABELING OF HIV-1 REVERSE-TRANSCRIPTASE
    SHENG, NJ
    DENNIS, D
    BIOCHEMISTRY, 1993, 32 (18) : 4938 - 4942
12345